Cargando…

Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer

Detalles Bibliográficos
Autores principales: Jung, Heiyoun, Bischof, Ashley, Ebsworth, Karen, Ertl, Linda, Schall, Thomas, Charo, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649449/
http://dx.doi.org/10.1186/2051-1426-3-S2-P227
_version_ 1782401360387375104
author Jung, Heiyoun
Bischof, Ashley
Ebsworth, Karen
Ertl, Linda
Schall, Thomas
Charo, Israel
author_facet Jung, Heiyoun
Bischof, Ashley
Ebsworth, Karen
Ertl, Linda
Schall, Thomas
Charo, Israel
author_sort Jung, Heiyoun
collection PubMed
description
format Online
Article
Text
id pubmed-4649449
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46494492015-11-24 Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer Jung, Heiyoun Bischof, Ashley Ebsworth, Karen Ertl, Linda Schall, Thomas Charo, Israel J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649449/ http://dx.doi.org/10.1186/2051-1426-3-S2-P227 Text en Copyright © 2015 Jung et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Jung, Heiyoun
Bischof, Ashley
Ebsworth, Karen
Ertl, Linda
Schall, Thomas
Charo, Israel
Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
title Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
title_full Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
title_fullStr Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
title_full_unstemmed Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
title_short Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
title_sort combination therapy of chemokine receptor inhibition plus pdl-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649449/
http://dx.doi.org/10.1186/2051-1426-3-S2-P227
work_keys_str_mv AT jungheiyoun combinationtherapyofchemokinereceptorinhibitionpluspdl1blockadepotentiatesantitumoreffectsinamurinemodelofbreastcancer
AT bischofashley combinationtherapyofchemokinereceptorinhibitionpluspdl1blockadepotentiatesantitumoreffectsinamurinemodelofbreastcancer
AT ebsworthkaren combinationtherapyofchemokinereceptorinhibitionpluspdl1blockadepotentiatesantitumoreffectsinamurinemodelofbreastcancer
AT ertllinda combinationtherapyofchemokinereceptorinhibitionpluspdl1blockadepotentiatesantitumoreffectsinamurinemodelofbreastcancer
AT schallthomas combinationtherapyofchemokinereceptorinhibitionpluspdl1blockadepotentiatesantitumoreffectsinamurinemodelofbreastcancer
AT charoisrael combinationtherapyofchemokinereceptorinhibitionpluspdl1blockadepotentiatesantitumoreffectsinamurinemodelofbreastcancer